Crosslinker enhanced repair of connective tissues
A protein crosslinker delivery device includes a body and a protein crosslinker held in a synthetic or natural biodegradable polymer. The body, a coating on the body, or an attachment to the body can contain the protein crosslinker holding biodegradable polymer. The release rate of the crosslinker and total amount of crosslinker released can be controlled by varying the concentration of the crosslinker and by varying the composition and structural characteristics of the degradable polymer. Surface eroding, bulk eroding and naturally occurring biodegradable polymers can be used in conjunction with a variety of nontoxic or minimally-toxic protein crosslinking agents. The devices can be used to treat mechanically damaged, deformed, and nutritionally deficient connective or soft tissues such as the knee meniscus, the spinal disc, the cornea, ligaments and tendons, the soft palate, and skin.
1. A biocompatible fabricated protein crosslinker delivery device for treating a connective tissue or soft tissue injury in vivo with an animal or human, comprising:
a biocompatible body, wherein the biocompatible body is comprised of a synthetic polymer or a metal and is selected from the group consisting of a patch, an arrow, a dart, a tack, a suture and a staple; and
a dry biodegradable polymer dip coated on to the biocompatible body, wherein the biodegradable polymer comprises a copolymer of poly(lactic acid) and poly(glycolic acid) (PLGA) encapsulating genipin and a plasticizer, wherein degradation of the biodegradable polymer allows for release of genipin in vivo.
2. The device of claim 1 , further including a basic salt.
3. The device of claim 2 , wherein said basic salt is selected from a group of salts consisting of calcium carbonate, calcium hydroxyapatite, sodium bicarbonate, 2-amino-2-hydroxymethyl-prysane-1,3-diol(tris), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and mixtures thereof.
4. The device of claim 1 , wherein said body is porous.
5. The device of claim 1 , wherein said biodegradable polymer fully erodes within 240 hours.
6. The device of claim 1 , wherein said biodegradable polymer fully erodes within 72 hours.
7. The device of claim 1 , wherein said biodegradable polymer fully erodes within 48 hours.
8. The device of claim 1 , wherein said biodegradable polymer fully erodes within 24 hours.
9. The device of claim 1 , wherein said biodegradable polymer fully erodes within 10 hours.
10. A method of treating an injury to a connective tissue or soft tissue of a patient, comprising:
contacting said injured connective tissue or soft tissue with a protein crosslinker delivery device as set forth in claim 1 .
11. The device of claim 1 , wherein the plasticizer is poly ethylene glycol (PEG).
12. The device of claim 1 , wherein the biocompatible body is non-adsorbable.
13. The device of claim 1 , wherein the biocompatible body is biodegradable.
14. The device of claim 1 , wherein the biocompatible body comprises poly(glycolic) acid.
15. The device of claim 1 , wherein the biocompatible body comprises polydioxone.
16. The device of claim 1 , wherein the biocompatible body comprises polypropylene.
17. The device of claim 1 , wherein the biocompatible body comprises nylon.
18. The device of claim 1 , further comprising an outer layer of biodegradable polymer-embedded crosslinker.
19. The device of claim 18 , wherein the outer layer biodegradable polymer is different from the biodegradable polymer dip coated on to the biocompatible body.
20. The device of claim 1 , wherein the biocompatible body comprises a polymer material selected from the group consisting of polyvinylacetate, polyvinylchloride, polypropylene, polyetheretherketone (PEEK), polysulfone, polyethersulfone, polytetrafluoroethylene, polyethylene, polyurethane, polyetherimide and polycarbonate.
21. The device of claim 1 , wherein the biocompatible body comprises a biocompatible metal selected from the group consisting of stainless steel, titanium, tantalum, titanium alloys and cobalt alloys.